µMap-FFPE: A High-Resolution Protein Proximity Labeling Platform for Formalin-Fixed Paraffin-Embedded Tissue Samples

01 April 2025, Version 1

Abstract

Many disease states can be understood by elucidating small-scale biomolecular protein interaction networks, or microenvironments. Recently, photoproximity labeling methods, like µMap, have emerged as high-resolution techniques to study key spatial relationships in subcellular architectures. However, in vitro models typically lack cell type heterogeneity and three dimensionality, integral parameters that limit the translation of in vitro findings to the clinic. To this end, formalin-fixed paraffin-embedded (FFPE) tissues serve as an invaluable model system for biomedical research by fixing complex multi-cell interaction networks in their natural environment. Thus, identifying microscale interactions in these samples would provide important clinical insight. Yet, the underlying chemistry of photoproximity labeling is challenged by formalin-fixation and de-crosslinking, precluding its application. Herein, we report the development of competent labeling system, µMap-FFPE, enabling the comparison of CD20’s interactome between healthy and cancerous cells or preserved patient tissues.

Keywords

Proximity Labeling
FFPE Tissue
B-cell Lymphoma

Supplementary materials

Title
Description
Actions
Title
Combined Raw Proteomics Data – CD20 Labeling
Description
Raw proteomics data for CD20 labeling on B-cell lines (using µ-Map-blue) and FFPE tissues (using µ-Map-FFPE). A separate sheet containing the enriched hits for each run is also included.
Actions
Title
Proteomics Data for BSA Labeling
Description
Open search for mass modifications which identifies the Bt-An-O2 adduct.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.